Cleared Traditional

K243555 - LED light therapy mask (E43, E32, E49B, E49C, E100B, E100C, E103B, E104B, E106A, E108A) (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K243555 · Shenzhen Eyco Technology Co., Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2025
Decision
79d
Days
Class 2
Risk

K243555 is an FDA 510(k) clearance for the LED light therapy mask (E43, E32, E49B, E49C, E100B, E100C, E103B, E104B, E10.... Classified as Over-the-counter Powered Light Based Laser For Acne (product code OLP), Class II - Special Controls.

Submitted by Shenzhen Eyco Technology Co., Ltd. (Guangdong, CN). The FDA issued a Cleared decision on February 5, 2025 after a review of 79 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Shenzhen Eyco Technology Co., Ltd. devices

Submission Details

510(k) Number K243555 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 2024
Decision Date February 05, 2025
Days to Decision 79 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 114d · This submission: 79d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OLP Over-the-counter Powered Light Based Laser For Acne
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition The Device Is Intended For Over-the-counter (otc) Use To Treat Patients With Mild To Moderate Acne Vulgaris. The Device Is Intended To Emit Energy In The Red And Blue Region Of The Spectrum, Specifically Indicated To Treat Mild To Moderate Acne Vulgaris.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Share Info (Guangzhou) Medical Consultant , Ltd.
Lee Cassie

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OLP Over-the-counter Powered Light Based Laser For Acne

All 50
Devices cleared under the same product code (OLP) and FDA review panel - the closest regulatory comparables to K243555.
LUSTRE GoGlow Advanced LED Patches (PR8001, PR9001)
K253878 · Shenzhen Kaiyan Medical Equipment Co., Ltd. · Mar 2026
Erchonia EVRL
K251843 · Erchonia Corporation · Sep 2025
LED Light Therapy Mask (RT01)
K242068 · Ningbo Dechang Electrical Machinery Made Co.,Ltd · Apr 2025
BLU TOTALE (Model: ENEOB852)
K232656 · Premier North America, Inc. · Nov 2023
PMD Clean Acne, Model: 4004-CABLUE-NA, 4004-GREY-NA, 4004-YELLOW-NA, 4004-PSTO-NA, 4004-LPUR-NA, 4004-CABLUE-NA-INT, 4004-GREY-INT, 4004-YELLOW-INT, 4004-PSTO-INT, 4004-LPUR-INT
K230490 · Dongguan Hunter Electronic Technology Co., Ltd. · Oct 2023
LUSTRE 3XPRESS Light Beauty Therapy patches, model: PR6001, PR5001
K230720 · Light Tree Ventures Europe B.V. · Jul 2023